A carregar...
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
Major depressive disorder (MDD) is a leading cause of disability worldwide. Current first line therapies target modulation of the monoamine system. A large variety of agents are currently available that effectively alter monoamine levels; however, approximately one third of MDD patients remain treat...
Na minha lista:
| Publicado no: | Curr Neuropharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bentham Science Publishers
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4761634/ https://ncbi.nlm.nih.gov/pubmed/26467412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150630175044 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|